225
Participants
Start Date
May 1, 2015
Primary Completion Date
December 31, 2020
Study Completion Date
September 30, 2022
FDC I/H
All subjects in both groups will be initiated on drug, FDC I/H with dose titrated up to target doses based on clinical guidelines
Montefiore Medical Center Bronx New York, The Bronx
University of Pittsburgh Medical Center, Pittsburgh
Temple University Medical Center, Philadelphia
University of Maryland Medical Center, Baltimore
University of Virginia, Charlottesville
University of South Carolina, Charleston
Morehouse School of Medicine, Atlanta
Emory University, Atlanta
University of Alabama Medical Center, Tuscaloosa
Stern Cardiovascular Foundation, Germantown
MetroHealth System, Cleveland
Henry Ford Health System, Detroit
Northwestern University, Chicago
University of Illinois of Chicago, Chicago
Tulane University Heart and Vascular Institute, New Orleans
Ochsner, New Orleans
Baylor College of Medicine, Houston
Massachsetts General Hospital, Boston
Rutgers University Health Center, Newark
University of Pittsburgh
OTHER